Immunovant had a revenue of 160.00K in the quarter ending Mar 31, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 160.00K, Increased -89.33%. In the fiscal year ending Mar 31, 2025, Immunovant had annual revenue of 0.00 with ― growth.